Two powdered-formula outbreaks of infant botulism are closed. The question parents keep asking is still open: how did Clostridium botulinum get into formula in the first place?
This is a news briefing, not medical advice. If an infant has constipation, a weak cry, poor feeding, floppy muscles, or trouble breathing, seek emergency care. Infant botulism is treated with BabyBIG, and clinicians do not wait for a lab result to start that conversation.
What happened
In late 2025, ByHeart Whole Nutrition powdered infant formula was linked to the first known cluster of infant botulism tied to formula. Federal counts settled around 51 infants across 19 states hospitalized, with no deaths attributed to that outbreak. All ByHeart infant formula was recalled in November 2025.
In spring 2026 a second cluster appeared, tied to Nara Organics Whole Milk Organic Powdered Infant Formula. Four confirmed cases were reported in California, Pennsylvania, and Washington, with onset in April and May 2026. CDC declared that outbreak over on 27 August 2026. No new cases had been added since early July.
The new development this week is not another illness count. On 8 October 2026, Spotlight on America and food-safety attorney Bill Marler published follow-ups arguing that FDA still has not answered the origin question. Reporting based on agency documents said investigators traced milk to a set of dairies and did not publicly name those farms or show a full farm investigation. ByHeart told reporters it did not have visibility into which farms its supplier used.
What changed in the investigation
FDA has said the Nara lots were made with milk supplied by Organic West Milk and spray-dried by Dairy Farmers of America — the same supplier path linked to the ByHeart outbreak. Whole-genome sequencing of the toxin-producing strain matched across the two outbreaks, which points to a shared source rather than two unrelated accidents in the home.
Investigators cultured C. botulinum type A from an opened can fed to a sick infant and later from unopened cans. That finding matters: contamination happened before the product reached families. FDA has said it still does not have enough evidence to say whether the milk was contaminated before drying or during drying. The root-cause investigation remains open.
A separate 2025–2026 event, not botulism, involved cereulide (a heat-stable toxin from Bacillus cereus) in arachidonic-acid oil used to match the fatty-acid profile of breast milk. FDA has since pressed formula makers to tighten supplier oversight. The pattern across both events is ingredient supply, not how a parent mixed a bottle.
Background parents actually need
Infant botulism is rare. Spores of C. botulinum are common in soil and dust. In infants under about 12 months, those spores can grow in the gut and make toxin. Honey is the classic avoidable source. Powdered formula was not, until these outbreaks, on that list.
Symptoms can show up weeks after exposure: constipation, weak suck, loss of head control, a flat facial expression, and a weak cry. Treatment is supportive care plus BabyBIG, the botulism immune globulin produced by the California Department of Public Health. Families in both outbreaks were treated; deaths were not reported in the published counts.
Competing viewpoints
Industry and regulators are not saying the same thing about what should happen next.
A July 2026 roundtable convened by the Reagan-Udall Foundation, with funding from ByHeart and the International Dairy Foods Association, published recommendations in September. The report treats C. botulinum as a powdered-formula hazard that the category had not controlled for, and calls for shared testing methods, validated preventive controls, and data-sharing along the dairy chain. That view says the science was missing, so the fix is better controls and thresholds.
Consumer advocates, including Barbara Kowalcyk of George Washington University’s Institute for Food Safety and Nutrition Security, call the traceability system broken. Their point is narrower: if a manufacturer cannot name the farms in its milk supply, it cannot show parents the hazard was found and stopped. Marler’s 5 October note makes the same argument from the outbreak files: 22 dairies in internal documents, no public farm list, no clear evidence of farm visits.
FDA’s public position sits between them. The agency has linked the two outbreaks through suppliers and genetics, ended the case counts, and said the root cause is still under investigation. It has not published a farm-level source.
What to do this week
- If you still have ByHeart or recalled Nara Organics powdered formula, do not use it. Follow the recall instructions on FDA.gov rather than a social post.
- Other brands were not named in these two outbreaks. Switching formula is a pediatric decision if your baby is thriving on a product that was not recalled.
- Do not give honey to an infant under 12 months. That advice did not change.
- Raw milk is a separate risk. On 6 October 2026 the American Academy of Pediatrics renewed its call to ban raw-milk sales, citing bacteria and an emerging H5N1 concern. Pasteurized dairy is the AAP recommendation for children and pregnant people.
What to watch next
Three things would change this story. A published root-cause finding that names the step (farm, hauler, dryer, or later ingredient). A testing threshold for C. botulinum in formula ingredients that companies actually use. And whether FDA’s supplier-oversight letter turns into enforceable checks, or stays a letter.
Until one of those lands, the practical parent version is short: the recalled cans are the hazard you can still control, and the unanswered factory question is the one regulators still owe you.
Sources: FDA outbreak updates; CDC outbreak closure for Nara Organics (27 August 2026); Spotlight on America, 8 October 2026; Marler Blog, 5 October 2026; Reagan-Udall Foundation roundtable report, September 2026; AAP raw-milk policy, 6 October 2026.
Comments (0)
No comments yet.
Sign in to comment.